共 50 条
- [1] Effects of Once-Daily, Extended-Release Memantine (28 mg/day) on Cognitive Domains in Patients with Moderate to Severe Alzheimer's DiseaseANNALS OF NEUROLOGY, 2011, 70 : S54 - S55Tocco, MichaelHendrix, SuzanneMiller, Michael L.Pejovic, VojislavGraham, Stephen M.
- [2] Extended-Release Memantine (28 mg, Once Daily) and Sustained Behavioral Improvement: Post hoc Responder Analysis From a Randomized Trial in Patients With Moderate to Severe Alzheimer's DiseaseAMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 20 (03): : S130 - S130Cummings, Jeffrey L.Hendrix, SuzanneMiller, MichaelPejovic, VojislavGraham, Stephen M.Tocco, Michael
- [3] Benefits of Once-Daily, Extended-Release Memantine on Caregiver Distress in Patients with Moderate to Severe Alzheimer's DiseaseANNALS OF NEUROLOGY, 2010, 68 (04) : S47 - S48Grossberg, George T.Manes, FacundoAllegri, RicardoGutierrez Robledo, Luis MiguelGloger, SergioXie, LeiDaniel Jia, XinweiPerhach, James L.Tocco, MichaelGraham, Stephen M.
- [4] Extended-Release Memantine (28 mg, Once Daily) and Sustained Behavioral Improvement: Post Hoc Responder Analysis from a Randomized Trial in Patients with Moderate to Severe Alzheimer's DiseaseNEUROLOGY, 2012, 78Cummings, JeffreyHendrix, SuzanneMiller, MichaelPejovic, VojislavGraham, StephenTocco, Michael
- [5] Sustained Cognitive Improvement with Extended-Release Memantine (28 mg, Once Daily) in Moderate to Severe Alzheimer's DiseaseANNALS OF NEUROLOGY, 2012, 72 : S42 - S42Tocco, MichaelHendrix, SuzanneMiller, Michael L.Pejovic, VojislavGraham, Stephen M.
- [6] Effects of Extended-Release Memantine (28 mg, Once Daily) on Language and Communication Abilities in Patients with Moderate to Severe Alzheimer's DiseaseANNALS OF NEUROLOGY, 2012, 72 : S52 - S53Tocco, MichaelHendrix, SuzanneMiller, Michael L.Pejovic, VojislavGraham, Stephen M.
- [7] Extended-release memantine (28 mg, once daily) and sustained cognitive improvement: Post hoc responder analysis from a randomized trial in patients with moderate to severe Alzheimer's disease.JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 : S197 - S197Tocco, M.Hendrix, S.Miller, M. L.Pejovic, V.Graham, S. M.
- [8] Effects of Once-Daily, Extended-Release Memantine on Individual Activities of Daily Living in Patients with Moderate to Severe Alzheimer's DiseaseANNALS OF NEUROLOGY, 2011, 70 : S57 - S58Tocco, MichaelHendrix, SuzanneMiller, Michael L.Pejovic, VojislavGraham, Stephen M.
- [9] Response across Multiple Outcome Measures in Patients with Moderate to Severe Alzheimer's Disease Taking Extended-Release Memantine (28 mg, Once Daily)ANNALS OF NEUROLOGY, 2012, 72 : S42 - S42Graham, Stephen M.Hendrix, SuzanneMiller, Michael L.Pejovic, VojislavTocco, Michael
- [10] Safety and Tolerability of a Once-Daily, Extended-Release Memantine Formulation (28 mg) in Patients with Moderate to Severe Alzheimer's Disease: Results of a 52-Week Open-Label TrialNEUROLOGY, 2010, 74 (09) : A269 - A269Meyers, Barnett S.Lin, MinGraham, Stephen M.